Literature DB >> 15309305

[Botulinum toxin in urology. Indications and results].

B Schurch1, A Reitz.   

Abstract

Botulinum toxin is a presynaptic neuromuscular blocking agent inducing selective and reversible muscle weakness for up to several months when injected intramuscularly. In urology, indications for botulinum A toxin injections have been reported in detrusor-sphincter dyssynergia, neurogenic detrusor over activity and benign prostatic hyperplasia. Randomized controlled studies are available for these indications. During the last few years, the indications have been expanded to include chronic retention, chronic pelvic pain, and motor and sensory urinary urge incontinence. However, further research is needed on the efficacy and safety as well as the dilution, dose and number of injection sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309305     DOI: 10.1007/s00120-004-0652-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  30 in total

1.  Treatment of neurogenic incontinence with botulinum toxin A.

Authors:  B Schurch; D M Schmid; M Stöhrer
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

2.  Extensor digitorum brevis test and resistance to botulinum toxin type A.

Authors:  Paul H Gordon; Clifton L Gooch; Paul E Greene
Journal:  Muscle Nerve       Date:  2002-12       Impact factor: 3.217

3.  Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.

Authors:  G-Y R Hsiung; S K Das; R Ranawaya; A-L Lafontaine; O Suchowersky
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

Review 4.  The male chronic pelvic pain syndrome.

Authors:  D H Zermann; M Ishigooka; R Doggweiler-Wiygul; J Schubert; R A Schmidt
Journal:  World J Urol       Date:  2001-06       Impact factor: 4.226

5.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.

Authors:  B Schurch; M Stöhrer; G Kramer; D M Schmid; G Gaul; D Hauri
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

6.  Botox-induced prostatic involution.

Authors:  R Doggweiler; D H Zermann; M Ishigooka; R A Schmidt
Journal:  Prostate       Date:  1998-09-15       Impact factor: 4.104

7.  Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor.

Authors:  B Schurch; A Reitz; G Tenti
Journal:  Spinal Cord       Date:  2004-06       Impact factor: 2.772

8.  Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.

Authors:  Giorgio Maria; Giuseppe Brisinda; Ignazio Massimo Civello; Anna Rita Bentivoglio; Gabriele Sganga; Alberto Albanese
Journal:  Urology       Date:  2003-08       Impact factor: 2.649

9.  Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia.

Authors:  Marcus Riccabona; Mark Koen; Monica Schindler; Beckers Goedele; Armin Pycha; Lukas Lusuardi; Stuart B Bauer
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

10.  Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.

Authors:  Hann-Chorng Kuo
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

View more
  2 in total

1.  [Intravesical therapy for overactive bladder].

Authors:  J Pannek; U Grigoleit; R Wormland; M Goepel
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

2.  [Botulinum toxin A injection for treatment-refractory giggle incontinence].

Authors:  B Wefer; C Seif; C van der Horst; K P Jünemann; P M Braun
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.